TW201000010A - Antimicrobial compositions and methods of making same - Google Patents
Antimicrobial compositions and methods of making same Download PDFInfo
- Publication number
- TW201000010A TW201000010A TW097142335A TW97142335A TW201000010A TW 201000010 A TW201000010 A TW 201000010A TW 097142335 A TW097142335 A TW 097142335A TW 97142335 A TW97142335 A TW 97142335A TW 201000010 A TW201000010 A TW 201000010A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- polymeric material
- antibacterial
- decane
- hydrogen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 10
- 239000000203 mixture Substances 0.000 title description 15
- -1 hydrocarbyl halide Chemical class 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 40
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- 238000005580 one pot reaction Methods 0.000 claims abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 58
- 229920000742 Cotton Polymers 0.000 claims description 24
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 18
- 239000000460 chlorine Substances 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical class CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 10
- 229920000075 poly(4-vinylpyridine) Polymers 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 8
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical group CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Chemical group 0.000 claims description 7
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 239000004575 stone Substances 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 4
- OVINRBKOGQBTFM-UHFFFAOYSA-N COC(CCCCCCCCC)(OC)OC.ClCCC Chemical group COC(CCCCCCCCC)(OC)OC.ClCCC OVINRBKOGQBTFM-UHFFFAOYSA-N 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 claims description 2
- 229960003750 ethyl chloride Drugs 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 239000002861 polymer material Substances 0.000 claims description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 abstract description 11
- 239000011248 coating agent Substances 0.000 abstract description 9
- 238000000576 coating method Methods 0.000 abstract description 9
- 239000000758 substrate Substances 0.000 abstract description 9
- 238000011282 treatment Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 3
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 abstract description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 22
- 239000004744 fabric Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 239000011521 glass Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 239000003242 anti bacterial agent Substances 0.000 description 14
- 238000004140 cleaning Methods 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 150000001350 alkyl halides Chemical class 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 238000007306 functionalization reaction Methods 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000005956 quaternization reaction Methods 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 239000012209 synthetic fiber Substances 0.000 description 6
- 229920002994 synthetic fiber Polymers 0.000 description 6
- LSXKDWGTSHCFPP-UHFFFAOYSA-N 1-bromoheptane Chemical compound CCCCCCCBr LSXKDWGTSHCFPP-UHFFFAOYSA-N 0.000 description 5
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 5
- 239000003973 paint Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 230000002485 urinary effect Effects 0.000 description 5
- OXYZDRAJMHGSMW-UHFFFAOYSA-N 3-chloropropyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)CCCCl OXYZDRAJMHGSMW-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000191940 Staphylococcus Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 241000186359 Mycobacterium Species 0.000 description 3
- 241000589886 Treponema Species 0.000 description 3
- 150000001555 benzenes Chemical class 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- 239000004566 building material Substances 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 3
- 125000004965 chloroalkyl group Chemical group 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- KNKRKFALVUDBJE-UHFFFAOYSA-N 1,2-dichloropropane Chemical compound CC(Cl)CCl KNKRKFALVUDBJE-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- VCMGLJRCTUBQGF-UHFFFAOYSA-N 1-decoxytridecane Chemical compound CCCCCCCCCCCCCOCCCCCCCCCC VCMGLJRCTUBQGF-UHFFFAOYSA-N 0.000 description 2
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000011280 coal tar Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- RITLWVCWRVWWTI-UHFFFAOYSA-N ethylbenzene;hydrochloride Chemical compound Cl.CCC1=CC=CC=C1 RITLWVCWRVWWTI-UHFFFAOYSA-N 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- LIXVMPBOGDCSRM-UHFFFAOYSA-N nonylbenzene Chemical compound CCCCCCCCCC1=CC=CC=C1 LIXVMPBOGDCSRM-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- 239000005011 phenolic resin Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920006122 polyamide resin Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical group 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 238000010517 secondary reaction Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 241001673062 Achromobacter xylosoxidans Species 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000606660 Bartonella Species 0.000 description 1
- 241000606685 Bartonella bacilliformis Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000589969 Borreliella burgdorferi Species 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- WDACDCSKBJPAIP-UHFFFAOYSA-N COC(CCCCCCCCC)(OC)OC.CCC Chemical compound COC(CCCCCCCCC)(OC)OC.CCC WDACDCSKBJPAIP-UHFFFAOYSA-N 0.000 description 1
- ZJTXVVPVCRKEBE-UHFFFAOYSA-N COC(CCCCCCCCC)(OC)OC.NCCC Chemical compound COC(CCCCCCCCC)(OC)OC.NCCC ZJTXVVPVCRKEBE-UHFFFAOYSA-N 0.000 description 1
- 101100459439 Caenorhabditis elegans nac-2 gene Proteins 0.000 description 1
- 101100194322 Caenorhabditis elegans rei-1 gene Proteins 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241001647378 Chlamydia psittaci Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 241000588879 Chromobacterium violaceum Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241001517041 Corynebacterium jeikeium Species 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- 241000588878 Eikenella corrodens Species 0.000 description 1
- 241000589566 Elizabethkingia meningoseptica Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- 241000186811 Erysipelothrix Species 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 241000207201 Gardnerella vaginalis Species 0.000 description 1
- 241000193789 Gemella Species 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000271915 Hydrophis Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241000588621 Moraxella Species 0.000 description 1
- 241001502334 Mycobacterium avium complex bacterium Species 0.000 description 1
- 241000187478 Mycobacterium chelonae Species 0.000 description 1
- 241000186363 Mycobacterium kansasii Species 0.000 description 1
- 241000186362 Mycobacterium leprae Species 0.000 description 1
- 241000187492 Mycobacterium marinum Species 0.000 description 1
- 241000187490 Mycobacterium scrofulaceum Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- 241000187495 Mycobacterium terrae Species 0.000 description 1
- 241000187917 Mycobacterium ulcerans Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000206591 Peptococcus Species 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588777 Providencia rettgeri Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 101100172720 Rattus norvegicus Ces1e gene Proteins 0.000 description 1
- 241000606697 Rickettsia prowazekii Species 0.000 description 1
- 241000606695 Rickettsia rickettsii Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241001147687 Staphylococcus auricularis Species 0.000 description 1
- 241001147736 Staphylococcus capitis Species 0.000 description 1
- 241001147698 Staphylococcus cohnii Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 1
- 241000192087 Staphylococcus hominis Species 0.000 description 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 1
- 241000192099 Staphylococcus schleiferi Species 0.000 description 1
- 241000191973 Staphylococcus xylosus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000194008 Streptococcus anginosus Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607265 Vibrio vulnificus Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000002742 anti-folding effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 229940092528 bartonella bacilliformis Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000005358 mercaptoalkyl group Chemical group 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000002644 respiratory therapy Methods 0.000 description 1
- 229940046939 rickettsia prowazekii Drugs 0.000 description 1
- 229940075118 rickettsia rickettsii Drugs 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
201000010 九、發明說明: 本發明之交互參考資料 t明主張美國暫時性申請案第_46,347號,細年6月 日#’及美國暫時性申請案第_46,9〇〇號,2〇〇7年6月沈 曰申請之權利,該些揭露内容在此以參考方式併人本發明並成 為本發明說明書的一部份。 【發明所屬之技術領域】 本發明係有關於一種製備曱矽烷化聚(Ν-烷基-4-乙 烯吡錠)四級銨鹽族群的方法,曱矽烷化聚(Ν_烷基_4_ 乙稀吼鍵)四級銨鹽族群適合作為處理基材表面使其具 有抗菌效果之塗佈材料。 【先前技術】 4-乙烯吡啶之四級聚合物已經被證實在水溶液中具 有抗囷性質並且當塗佈於表面時可以在接觸該表面時去 除以空氣為傳媒的微生物。請參考例如Pr〇c. Nat 1. Acad. Sci. USA, 98, 5981 (2001); C&EN, May 28, 2001, page 13; Biotechnol. Lett., 24, 801 (2002);201000010 IX. INSTRUCTIONS: The cross-references of the present invention are as follows: US Provisional Application No. _46, 347, Fine Year June Day #' and US Temporary Application No. _46,9 ,, 2〇〇 The invention is hereby incorporated by reference in its entirety in its entirety in its entirety in its entirety in its entirety in the extent of the disclosure of the disclosure. TECHNICAL FIELD OF THE INVENTION The present invention relates to a process for preparing a decaneated poly(anthracene-alkyl-4-vinylpyridinium) quaternary ammonium salt group, decane-polymerized poly(Ν_alkyl_4_B The quaternary ammonium salt group is suitable as a coating material for treating the surface of the substrate to have an antibacterial effect. [Prior Art] The 4-stage polymer of 4-vinylpyridine has been confirmed to have anti-mite properties in an aqueous solution and to remove air-mediated microorganisms upon contact with the surface when applied to a surface. See, for example, Pr〇c. Nat 1. Acad. Sci. USA, 98, 5981 (2001); C&EN, May 28, 2001, page 13; Biotechnol. Lett., 24, 801 (2002);
Biotechnol. Bioeng., 79, 466 (2002); and Polymeric Materials: Science & Engineering, 91, 814 (2004) 荨文獻資料。 又如美國專利公開第US-2003-0091641 - A 1號公開一 種使表面官能化以賦予抗菌效能之方法,其所述的四步 程序之方法包括1)將Si〇2奈米層沈積於基材上,2)利Biotechnol. Bioeng., 79, 466 (2002); and Polymeric Materials: Science & Engineering, 91, 814 (2004) 荨 Literature. A method of functionalizing a surface to impart antimicrobial efficacy is disclosed, for example, in U.S. Patent Publication No. US-2003-0091641 - A1, which comprises the step of: depositing a layer of Si 2 nanoparticle on a substrate. Material, 2) profit
201000010 用3-胺基丙烷三甲氧基矽烷使表面胺化,幻利用ι,4— 二溴丁烷使表面溴烷化,然後4)在溴烷的存在下利用烷 基-聚乙稀吡啶使經溴烷化的表面進行衍生作用。上述利 用1’4-二溴丁烷的方法的缺點在於:不可避免地會產生 雙向產物(㈣反應物的主鍊之觀均發生反應),造成 表面基團發生交聯而無法進—步往下進行官能化反應 (fimctionalization),而使反應為之中 以 達成經濟上的效益。 【發明内容】 具有抗菌表面的產物有高度的需求。此等表面較佳 地展現出抗Gram正型細菌(例如 =聰)及“負型細菌(尤灿·)的抗菌效果。本發明 種^過處理後具有抗菌性質之表面,包括玻璃(陶 f石材)表面以及織品表面(例如棉或合成化纖),上述 ^面展現出抗菌層十分耐用,制是㈣忍受重複性 的、循環性的洗滌清潔/清洗。 避免St術本::提出一種製備上述抗菌表面但又可 例如在表面基團官能化前先交聯等缺點 改質劑。方錢料定喊分子部分作為抗菌表面 Θ化^ t ^佳具體貫施缝供—製備高活性抗菌劑的 ft化方法,也提供—種新糾抗菌劑。 根據本U之—觀點,係提供有抗驗果的聚合材 201000010 料,其包括一具由下列所示化學式之單元重複所形成之 聚合物;201000010 Amination of the surface with 3-aminopropane trimethoxy decane, clarification of the surface bromine using iota, 4-dibromobutane, and then 4) using alkyl-polyvinyl pyridine in the presence of a bromo alkane Derivatization is carried out on the brominated surface. The above-mentioned method using 1'4-dibromobutane has the disadvantage that bidirectional products are inevitably produced (the reaction of the main chain of the (four) reactants is all reacted), causing the surface groups to crosslink and fail to proceed. The functionalization is carried out under the reaction, and the reaction is made to achieve economic benefits. SUMMARY OF THE INVENTION There is a high demand for products having an antimicrobial surface. These surfaces preferably exhibit an antibacterial effect against Gram positive bacteria (eg, Cong) and "negative bacteria (Youcan·). The surface of the present invention having antibacterial properties after treatment, including glass (Tao f Stone) surface and fabric surface (such as cotton or synthetic fiber), the above surface shows that the antibacterial layer is very durable, and the system is (4) tolerate repetitive, cyclic cleaning/cleaning. Avoid St.: Antibacterial surface, but can be cross-linked, for example, before the surface group functionalizes. The molecular part is called the molecular part as the antibacterial surface Θ化 ^ t ^ 佳 贯 施 — — — 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备The method further provides a new antibacterial agent. According to the present invention, a polymer material 201000010 which is resistant to test is provided, which comprises a polymer formed by repeating a unit of the chemical formula shown below;
其中R為經取代或未經取代之苯基;A為一Cm烷基 鏈;D為一 Cm烷基鏈;X為鹵素;及η為至少2。在一 具體實施例裡,R為一苯基。在另一具體實施例裡,X為 氣。在又一具體實施例裡,X為溴。在另一具體實施例裡, Α選自由曱撐(methylene)及乙撐(ethylene)所組成 之族群。在又一具體實施例裡,D為曱撐。在另一具體實 施例裡’ R為一被-(E)m- Si( - 0- Alk)3取代的苯基, 其中每個Aik分別為一匕-6烷基,E為含m個碳原子的氫基 二價碳基’及m 為〇到 12,例如 ’ -(E)m- Si( - 0- Alk)3 為在苯基上的對位取代基,其中每個Aik為甲基,及其中 ~(Ε)ΠΤ·為低碳烷撐基(alkylene)鏈,或E為具有化學式 ^ίΙ2-Ρ1ι~αί2-(:Η2-的基團,其中Ph為一苯基。在又一具體 貫施例裡’ η為2到1000,或50到200。在另一具體實施 7 201000010 例裡,係提供一包括具有抗菌效果之聚合材料的表面, 例如一玻璃表面,一石材表面、一木材表面,一聚合材 料,一織品表面,或至少一例如棉纖維等天然纖維。 本發明係提供一種製備一具有抗菌效果的聚合材料 之方法,該方法包括將氫基二價碳基氯化物、氯烷基矽 烷與聚(4-乙烯吡啶)併入一次反應混合物中,藉以獲得 具抗菌性質之甲矽烷化四級鹽。在一具體實施例裡,氫 基二價碳基的化學式為CnH2n+1-X,其中η為1到18, ❹ 而X為氯或溴'。在又一具體實施例裡,氫基二價碳基氯 化物選自由卜氯丁烷、1-溴庚烷、1-溴辛烷、氯化苯、 氣化乙基苯及氯化丙烯。在一具體實施例裡,鹵烷基矽 烷的化學式為(Alk-0-)3Si(-(E)m-Hal),其中每個Aik分 別是Ci-6烧基’ E為含有m個碳原子之氫基二價碳基,m為 0到12,Hal為氯或溴。在該觀點之又一具體實施例裡, 鹵烷基矽烷為γ-氯丙烷三曱氧基矽烷。在又一具體實施 例裡,聚(4-乙烯吡啶)的分子量為約10, 000 MW到約 q 180, 000 MW,或分子量約20, 000 MW。在一具體實施例裡, 具有抗菌效果之聚合材料至少50%被四級化。 在本發明中,係提供一種製備具有抗菌效果之聚合 材料的方法,該方法包括將氫基二價碳基氯化物及聚(4-乙烯吡啶)併入一次反應混合物,藉以具有抗菌性質之甲 矽烷化四級鹽。在具體實施例裡,氳基二價碳基氯化物 的化學式CnH2n+1-X,其中η為1到18,其中X為氯或溴。該 8 201000010 具體實施例裡,氫基二價碳基氯化物選自由1-氯丁烷、 1-溴庚烷、1-溴辛烷、氯化苯、氯化乙基苯及氯化丙烯 所組成之群組。在另一具體實施例裡,聚(4-乙烯吡啶) 的分子量為約10, 000 MW到約160, 000 MW,或約20, 000 MW°而具有抗菌效果之聚合材料至少5〇%被四級化。 本發明更提供一種使表面能抗細菌生長之方法,該 方法包括將採用藉由將氫基二價碳基氯化物、氯烷基矽 烧及聚(4-乙燦η比σ定)併入一次反應混合物而得之具有抗 〇 菌效果之聚合材料;及塗佈該具有抗菌效果之聚合材料 到一物品表面上,藉以使該表面具有抗菌效果。該具體 實施例裡,該物品表面為一棉纖維表面。另一具體實施 例裡’該物品表面為玻璃表面或石材表面。在該觀點之 一具體實施例裡,微生物為Gram-負型細菌,例如 Escherichia Coli, Pseudomonas aeruginosa,或 e/a /we⑽。在該觀點之一具體實施例裡, 微生物為Gram正型細菌,例如5亡5/?/?/7(9匸〇£^"5 ai/rei/5。 〇 本發明更提供一種使一表面能抗微生物生長的方 法’該方法包括採用藉由將氫基二價碳基氯化物與聚(4-乙烯吡啶)併入一次反應混合物而得之具有抗菌效果之 聚合材料;以及將該聚合材料塗佈到一物品表面,藉以使 該表面具有抗菌效果。在一具體實施例裡,該物品表面 為棉纖維表面。在另一具體實施例裡,該物品表面為一 玻璃表面或石材表面。在一具體實施例裡,微生物為一 201000010 種Gram種負型細菌,例如Fsaherj'cMa CoJj·, Pseudomonas aeruginosa, ο>τ Klebsi el a pneumoniae。 在另一具體實施例裡,為微生物為一種Gram正型細菌, 例如 Staphylococcus aureus。 為使能更進一步瞭解本發明之特徵及技術内容,請 參閱以下有關本發明之詳細說明與附圖,然而所附圖式 僅提供參考與說明用,並非用來對本發明加以限制者。 【實施方式】 以下描述及實施例係用以詳細說明本發明之具體實 施例。熟習此項技藝者將瞭解仍有許多涵蓋於本發明範 圍内之其他變體與改良。因此,特地例示性具體實施例 的說明應該不被視為限制本發明之範疇。 四級化抗菌齋丨_錮 本發明揭露利用具更多抗g活性 提供製備反坑夺胸G^ ^ 備抗夂聯反應之四級化鹽類的簡化方法。官能 化反應試劑,曱矽浐仆^ ^ ^吕月b 劍丫 四級鹽(II)係 化物(1),具氯燒基 广猶域说基鹵 院)⑵及聚(4、乙婦/氣丙燒三甲氧基石夕 f得。 ~ ⑶在無水條件下-次反應而 201000010Wherein R is a substituted or unsubstituted phenyl group; A is a Cm alkyl chain; D is a Cm alkyl chain; X is a halogen; and η is at least 2. In a specific embodiment, R is a phenyl group. In another embodiment, X is gas. In yet another embodiment, X is bromine. In another embodiment, the lanthanum is selected from the group consisting of methylene and ethylene. In yet another embodiment, D is a brace. In another embodiment, 'R is a phenyl group substituted with -(E)m-Si(-0-Alk)3, wherein each Aik is a 匕-6 alkyl group, and E is m carbon atoms. The hydrogen-based divalent carbon group ' and m of the atom are 〇 to 12, for example, '-(E)m-Si(-0-Alk)3 is a para-substituent on the phenyl group, wherein each Aik is a methyl group And its ~(Ε)ΠΤ· is a lower alkylene chain, or E is a group having the chemical formula ^Ρ2Ι1ι~αί2-(:Η2-, wherein Ph is a phenyl group. In the specific embodiment, 'η is 2 to 1000, or 50 to 200. In another embodiment 7, 201000010, a surface comprising a polymeric material having an antibacterial effect, such as a glass surface, a stone surface, and a a wood surface, a polymeric material, a fabric surface, or at least one natural fiber such as cotton fiber. The present invention provides a method of preparing a polymeric material having an antibacterial effect, the method comprising: hydrogen-based divalent carbon-based chloride, The chloroalkyl decane is combined with poly(4-vinylpyridine) in a single reaction mixture to obtain a methacrylated quaternary salt having antibacterial properties. In a specific embodiment, the hydrogen-based divalent carbon group has the formula CnH2n+1-X, wherein η is 1 to 18, and X is chlorine or bromine. In yet another embodiment, the hydrogen-based divalent carbon group The chloride is selected from the group consisting of chlorobutane, 1-bromoheptane, 1-bromooctane, chlorinated benzene, vaporized ethylbenzene, and chlorinated propylene. In one embodiment, the haloalkyl decane has the formula ( Alk-0-)3Si(-(E)m-Hal), wherein each Aik is a Ci-6 alkyl group, 'E is a hydrogen-based divalent carbon group containing m carbon atoms, m is 0 to 12, Hal In another embodiment of this aspect, the haloalkyl decane is gamma-chloropropane tridecyloxydecane. In yet another embodiment, the molecular weight of the poly(4-vinylpyridine) is about 10 000 MW to about q 180,000 MW, or a molecular weight of about 20,000 MW. In one embodiment, at least 50% of the polymeric material having an antibacterial effect is quaternized. In the present invention, a preparation is provided. A method of polymerizing a material having an antibacterial effect, the method comprising incorporating a hydrogen-based divalent carbon-based chloride and a poly(4-vinylpyridine) into a single reaction mixture, thereby having an antibacterial property a decaneated quaternary salt. In a particular embodiment, the fluorenyl divalent carbon-based chloride has the formula CnH2n+1-X, wherein η is from 1 to 18, wherein X is chlorine or bromine. The hydrogen-based divalent carbon-based chloride is selected from the group consisting of 1-chlorobutane, 1-bromoheptane, 1-bromooctane, chlorobenzene, ethylbenzene chloride, and chlorinated propylene. In a particular embodiment, the poly(4-vinylpyridine) has a molecular weight of from about 10,000 MW to about 16,000 MW, or about 20,000 MW, and at least 5% of the polymeric material having an antimicrobial effect is quaternized. The present invention further provides a method for making a surface resistant to bacterial growth, the method comprising incorporating by using a hydrogen-based divalent carbon-based chloride, a chloroalkyl group, and a poly(4-ethyl-n-n-ratio) a polymeric material having an antibacterial effect obtained by reacting the mixture once; and coating the polymeric material having an antibacterial effect onto the surface of an article to thereby impart an antibacterial effect to the surface. In this particular embodiment, the surface of the article is a cotton fiber surface. In another embodiment, the surface of the article is a glass surface or a stone surface. In a specific embodiment of this aspect, the microorganism is a Gram-negative bacterium, such as Escherichia Coli, Pseudomonas aeruginosa, or e/a /we (10). In one embodiment of this aspect, the microorganism is a Gram-positive bacterium, such as 5 dying 5/?/?/7 (9 匸〇£^" 5 ai/rei/5. 〇 The present invention further provides a Method for surface-energy-resistant growth 'This method comprises using a polymeric material having an antibacterial effect by incorporating a hydrogen-based divalent carbon-based chloride with poly(4-vinylpyridine) into a single reaction mixture; and polymerizing the polymerization The material is applied to the surface of an article to impart an antibacterial effect to the surface. In one embodiment, the surface of the article is a cotton fiber surface. In another embodiment, the surface of the article is a glass or stone surface. In one embodiment, the microorganism is a 201000010 Gram negative bacteria, such as Fsaherj'cMa CoJj., Pseudomonas aeruginosa, ο>τ Klebsi el a pneumoniae. In another embodiment, the microorganism is a Gram positive Type bacteria, such as Staphylococcus aureus. To enable a further understanding of the features and technical aspects of the present invention, reference should be made to the following detailed description of the invention and the accompanying drawings. The following description and examples are intended to be illustrative of specific embodiments of the present invention. Other variations and modifications are possible within the scope of the invention. Therefore, the description of the specific exemplary embodiments should not be construed as limiting the scope of the invention. Quaternized antibacterial 丨 丨 锢 锢 锢 锢 锢 锢 锢 锢 锢 锢 锢 锢 锢 制备 制备 制备 制备 制备 制备 制备Anti-Pit Chest G^ ^ A simplified method for preparing quaternary salts of anti-coupling reaction. Functionalization reagent, 曱矽浐 ^ ^ ^ ^ Lu Yue b Sword 丫 four-stage salt (II) system (1) , with chlorinated bases, said that the base of the brine base) (2) and poly (4, E women / gas propylene trimethyl sulphate f. ~ (3) in the absence of water - reaction 201000010
C「_H2rH^CI + (CHqO:^-Si-C3He-CI +(-CH2.CfH- CH2V ⑴ C2) P ol y(4 -vi nylp yrid in e) (3)C"_H2rH^CI + (CHqO:^-Si-C3He-CI +(-CH2.CfH- CH2V (1) C2) P ol y(4 -vi nylp yrid in e) (3)
Si(OCH3\Si(OCH3\
Silylated PVP Quaternized Salts (II) ❹ 或者是,可以藉由兩階段步驟完成上述反應。使烷 基鹵化物(1)與聚(4-乙烯吼啶)(3)反應產生部份四 級化PVP鹽(I)。部分四級化PVP鹽(I)本身即可以 作為對紡織品極具耐洗性的抗菌劑而無須再與具氯烷基 之石夕烧(例如γ-氯丙烧三曱氧基石夕烧)做進一步官能化 反應,或是再與具氯烷基之矽烷(例如γ-氯丙烷三曱氧 基矽烷)(2)反應產生曱矽烷化PVP四級鹽(II).Silylated PVP Quaternized Salts (II) ❹ Alternatively, the above reaction can be carried out in two stages. The alkyl halide (1) is reacted with poly(4-vinylcridine) (3) to produce a partially quaternized PVP salt (I). The partially quaternized PVP salt (I) itself can be used as an antibacterial agent which is very washable to textiles without having to be made with a chloroalkyl group (for example, γ-chloropropane tris oxide) Further functionalization, or further reacted with a chloroalkyl-containing decane (such as γ-chloropropane trimethoxy decane) (2) to produce a decylated PVP quaternary salt (II).
CnH2n-ri n 2「丨爿CnH2n-ri n 2"丨爿
Partially Quaternized PVF' Salt (I)Partially Quaternized PVF' Salt (I)
Si(OCH5)3Si(OCH5)3
Silylated PVP quaternized Salts(II) ❹ ❹ 201000010 1 碁二償碳皋H物(hvdromrhy】h叫Hr、 較佳地,虱基一價碳基鹵化物為一種化學式為 CnH2n+1-x之烷基鹵化物,其中X為選自由F,cl,Br,及1 =組成之族群者,其中特別卩π為較佳。在此所稱 “院基”乃廣義稱之’並且為其此項技藝者f遍所知 用者(不限於特殊定義),且在非限定解釋下指包含1 2 3’4,5,6,7,8,9,10, m,13, 14,15,16,’17, 18或更多碳原子之直鏈或支鏈、環狀或非環狀、飽和或 不飽和脂肪族碳水化合物(例如Ci ig烷基)。“少碳俨 基(lower aikyi)’’具有與絲相同之定義,但是= 1,2, 3, 4, 5,或6個碳原子(例如c卜6烷基)。“夕 ,絲(higher alkyi)’,具有與絲相同之定義,二 广包含7或8個’高達約18個或更多個碳原子(例如 仏-】8烷基)。代表性的直鏈烷基包括甲基,乙基,正丙烷, 括’正己基及其相似基團。代表性的支鏈 烷,括異丙烷’二級丁基,異丁基,特丁基,異戊美 及八相似基目。不麵絲在相鄰之碳原子之間包含至 =三鍵,(ί別稱為稀基或块基)。在此所稱“院 牙土 a yene)鏈係用以描述二個基團間不同鍵 之飽和碳鏈,例如甲烯化其絲Γ r_rHPR , “ Μ化基鍵(-〇,乙稀化基鏈 2 2 。低碳院撐基(alkylene)鏈”包含例如 z’ A 4,5,或6個碳原子。 12 201000010 在此所稱“環烷基”係指廣義的環烷基,乃廣義 稱之,並且為其此項技藝者普遍所知所用者(不限於特 殊定義),且在非限定解釋下指包含烷基基圑,包括單-, 二或多-同素環烷基環狀系統。環狀烷基分子部分 (也稱為“環烷基基團”或“同素環的環狀基團)包 括例如環丙烷、環丁基、環戊基、環己基、-ch2-環丙 烷、-CH2 -環丁基、-CH2 -環戊基、-CH2 -環己基、 環戊烯基、及環己烯基分子部分。在特別較佳實施例裡, 係使用直鏈烷基鹵化物。低碳烷基鹵化物也是特別較佳 的(例如η = 1到6)。雖然如此,具單鹵素取代基之烧 基鹵化物也是特別較佳的,在特定具體實施例裡,是可 以接受的或甚至需要併入二個或二個以上之il素取代基 (相同取代基或不同取代基)。特別較佳的烷基鹵化物包 括1 -氯丁燒、1 -溴庚烧、1 -溴辛烧及烧基氯化物。 雖然烷基鹵化物為較佳,但是也可以使用其他氫基 二價碳基鹵化物,例如芳基鹵化物、芳烷基ii化物及烷 基芳基鹵化物。在此所稱“芳基”乃廣義稱之,並且 為其此項技藝者普遍所知所用者(不限於特殊定義),且 在非限定解釋下指包含芳香族碳環分子部分,例如苯基 或萘基,包括單-,二及多-同素環芳香族環狀系統 (例如C6-18芳基)。在此所稱“芳烧基”乃廣義稱 之,並且為其此項技藝者普遍所知所用者(不限於特殊 定義),且在非限定解釋下指包含具至少一氫原子被一芳 13 201000010 基-子心刀(例如笨基 芳烷基基團包括c取代之烷 基),-CH2-(笨基H2'(11基), ,表性 a)及)’ 〜(CH2)2m、 H2'(2〜萘 稱之,並且為其t基)2。在此所稱;i(Ql2)3、(笨 殊定義),且在非^技藝者普遍所知所'用方者' 乃廣義 被-院基分子:::下指包含具有斤:;父 佳的芳絲-化物曱基)所取代之芳基。子 苯。. 括氣化苯'氣化甲基笨:氯 鹵烷基矽烷 氯烧基石夕 (Alk-〇-)3Si(Hai) ^里杈佳具有化學式 團;Hal為選自由匕^ ,其中Alk為相同或不同烷基基 其中又以ci為特別較伟Br’ f 1所組成之族群的*素’ ,,, 季又佳。Alk較佳選自低碳烷基基團, ❹ 歹,口甲基。E杈佳為C〗m2氫基二價碳基連結基團,例如烷 基鏈,或具有一將矽院連結於聚合物其餘處之苯基環的 氫基二價碳基團,如化學式為-CH2_ph—CH2_CH2-(其中 Ph為苯基)之基團。特別較佳者具有甲氧基基團者,例 如具有三個甲氧基基團及一個矽原子接有一終端C1取代 基之正丙烷(例如γ-氯丙烷三甲氧基矽烷)。 在特定具體實施例裡,鹵烷基矽烷可以不被用於反 應混合物,以得到作為抗菌官能反應劑:無矽烧之PVP四 14 201000010 級鹽。 聚乙稀°比°定 聚(4-乙烯吼唆)可以是任何具適當鍵長或分子量 的一種。聚(4-乙烯°比°定)具有2個°比錠(pyridinium) 單元至高達超過約1500個吡錠單元,較佳從約100, 200,300,400,或500個吡錠單元至高達約600, 700, 800, 900,或1000個吡錠單元。特別較佳為具約 ❿ 190個吡錠單元(相當於20, 000 MW)之聚(4-乙烯吡 啶)。此類聚(4-乙烯吡啶)可為市售品,例如 Indianapolis 公司之Reilly Indus Tries 所製造的 REILLINE™ 410 。在特定具體實施例裡,可以使用更高 分子量,例如高達約160, 000 MW或更高之聚(4-乙烯吡 咬)。 四級抗菌官能反應試劑 ❹ 如上所述,在特定具體實施例裡,鹵烷基矽烷可以 不被用於反應混合物,以得到作為抗菌官能反應劑:無 石夕烧之PVP四級鹽,例如: 15 201000010 •ch2- -ch2- -ch2-Silylated PVP quaternized Salts(II) ❹ ❹ 201000010 1 碁 偿 偿 偿 偿 H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H H And X is a group selected from the group consisting of F, cl, Br, and 1 =, wherein 卩 π is particularly preferred. The term "hospital base" is used herein to refer to it as a generalist. Known by the user (not limited to special definitions), and in the non-limiting interpretation, refers to 1 2 3'4,5,6,7,8,9,10, m,13, 14,15,16,'17 a linear or branched, cyclic or acyclic, saturated or unsaturated aliphatic carbohydrate of 18 or more carbon atoms (for example, Ci ig alkyl). "Lower aikyi" has The same definition of silk, but = 1, 2, 3, 4, 5, or 6 carbon atoms (such as c 6 alkyl). "Higher alkyi", with the same definition as silk, two broad Containing 7 or 8 'up to about 18 or more carbon atoms (eg, 仏-]8 alkyl). Representative linear alkyl groups include methyl, ethyl, n-propane, including 'n-hexyl and the like Group a branched alkane, including isopropane 'secondary butyl, isobutyl, tert-butyl, isoprene and eight similar bases. The no-filament filament contains between the adjacent carbon atoms to = three bonds, ( ί is not referred to as a dilute or a block base. The term "a yene" in this context is used to describe the saturated carbon chain of different bonds between two groups, such as methylation of its silk fissure r_rHPR, " The base bond (-〇, ethylidene chain 2 2 . low carbon alkylene chain) contains, for example, z' A 4, 5, or 6 carbon atoms. 12 201000010 "Cycloalkyl" as used herein Refers to a broadly defined cycloalkyl group, which is broadly referred to and generally used by those skilled in the art (not limited to a particular definition), and, in the non-limiting interpretation, includes alkyl-based oximes, including mono-, and Or a poly-homocyclic alkyl ring system. A cyclic alkyl molecular moiety (also referred to as a "cycloalkyl group" or a "cyclic group of a homocyclic ring" includes, for example, cyclopropane, cyclobutyl, and ring. a pentyl, cyclohexyl, -ch2-cyclopropane, -CH2-cyclobutyl, -CH2-cyclopentyl, -CH2-cyclohexyl, cyclopentenyl, and cyclohexenyl molecular moiety. In a preferred embodiment, a linear alkyl halide is used. Lower alkyl halides are also particularly preferred (e.g., η = 1 to 6). However, alkyl halides having a monohalogen substituent are particularly preferred. Preferably, in a particular embodiment, it is acceptable or even necessary to incorporate two or more il substituents (the same substituent or a different substituent). Particularly preferred alkyl halides include 1 - chloroprene, 1-bromoheptane, 1-bromooctane, and alkyl chloride. Although alkyl halides are preferred, other hydrogen-based divalent carbon-based halides such as aryl halides, aralkyl iodides and alkylaryl halides can also be used. The term "aryl" as used herein is used broadly and is generally used by those skilled in the art (not limited to a particular definition) and, by way of non-limiting explanation, refers to a moiety comprising an aromatic carbocyclic molecule, such as phenyl. Or naphthyl, including mono-, di- and poly-homocyclic aromatic ring systems (eg, C6-18 aryl). As used herein, "aryl burnt" is used broadly and is generally used by those skilled in the art (not limited to a particular definition) and, by way of non-limiting interpretation, means having at least one hydrogen atom 201000010 basal-sub-heart knives (eg, stupid aralkyl groups including c-substituted alkyl groups), -CH2-(stupyl H2'(11-yl), pheno-a) and)'~(CH2)2m, H2' (2~naphthalene, and its t group)2. As used herein; i(Ql2)3, (unclear definition), and generally known to the skilled person, the 'user' is a generalized-institutional molecule::: the lower finger contains the jin:; the father An aromatic aryl group substituted with an aromatic aryl group. Subbenzene. Including gasified benzene' gasification methyl stupid: chlorohaloalkyl decane chlorohydrin (Alk-〇-) 3Si (Hai) ^ Lijia has a chemical group; Hal is selected from 匕^, where Alk is the same Or a different alkyl group, which is also a group of ci, which is particularly composed of Br' f 1 , is good for the season. Alk is preferably selected from the group consisting of lower alkyl groups, oxime, and methyl groups. E is preferably a C 2 m hydrogen-based divalent carbon-based linking group, such as an alkyl chain, or a hydrogen-based divalent carbon group having a phenyl ring linking the broth to the rest of the polymer, as in the chemical formula a group of -CH2_ph-CH2_CH2- (where Ph is a phenyl group). Particularly preferred are those having a methoxy group, such as a positive propane having three methoxy groups and one terminal atom attached to a terminal C1 substituent (e.g., γ-chloropropane trimethoxy decane). In a particular embodiment, the haloalkyl decane may not be used in the reaction mixture to provide a PVP 4 2010 201010 grade salt as an antibacterial functional reactant: sputum-free. Polyethylene (polyvinyl hydride) can be any one having a suitable bond length or molecular weight. Poly (4-ethylene ° ratio) has 2 pyridinium units up to more than about 1500 pyridinium units, preferably from about 100, 200, 300, 400, or 500 pyridinium units up to Approximately 600, 700, 800, 900, or 1000 pyridinium units. Particularly preferred is poly(4-vinylpyridine) having about 190 pyridinium units (equivalent to 20,000 MW). Such poly(4-vinylpyridine) may be a commercially available product such as REILLINETM 410 manufactured by Reilly Indus Tries of Indianapolis Corporation. In particular embodiments, higher molecular weights, such as poly(4-vinylpyrene) of up to about 160,000 MW or higher, can be used. The fourth-order antibacterial functional reagent ❹ As described above, in a specific embodiment, the haloalkyl decane may not be used in the reaction mixture to obtain a PVP quaternary salt as an antibacterial functional reactant: no sinter, for example: 15 201000010 •ch2- -ch2- -ch2-
CnH2n+l CnH2n+ICnH2n+l CnH2n+I
或者是,鹵烷基矽烷可以用於反應產物,以產生曱 矽烧化四級鹽,例如: CH2--CH2—-CH2——一CH2Alternatively, a haloalkyl decane can be used in the reaction product to produce a cerium-burning quaternary salt such as: CH2--CH2--CH2--CH2
CnH2n+i CnH2n I Si(OCH3)3 可以藉由調整烷基鹵化物(或其他氫基二價碳基鹵 化物)在反應混合物裡的數量來得到四級化反應的不同 程度。在上述的二個聚合物結構裡,四級化反應的程度 為50%。在第二結構裡的曱矽氧化程度為25%。也可以有 利地利用較低程度的四級化反應,利於低於50%,像是5% -45%的四級彳反應;然而,通常較佳的情況是將四級化 反應最大化’例如高於50%的四級化反應,例如高達60%, 16 201000010 70%,80%,戰95队或1_。甲石夕氧化的程度可以藉由 二級化反應程度來控制,但是有利的是將甲$氧化^應 最大化,尤其是在需要極快速度的應用領域上。 〜 可以使用單-類型的重複單元,或是利用反應物與 不同分子部分的適當混合物獲得混合的化學重複單元。 ❹ ❹ 上述-次反應的優點為,其反應步驟比傳統使用3_ 胺基丙烧二甲氧基;^和1,4-二演了燒的方法更減少二 個步驟。所得的官能化產物(甲矽烷化PVP四級鹽)也 有下列優點:其可溶於水及/或有機溶劑,例如甲醇,因 此進-步處理及製財為㈣。此處理步驟可以包 括在基材材表面上進行業界所知的塗佈技術,例如浸 ,、浸潰、喷覆、氣溶、喷覆、刷塗、幕簾式塗佈、滾 Ρ、絲~、黃光製程、喷墨及相似技術 材(例如破璃)而言= UrT炫基侧基(例如三甲氧基”作基側基, 接;醇基團形成 所以很耐用且不容易移除(例如被沖掉於基材 可以利用任何^的方法塗佈。較佳地,將 二::- ί層塗在包括可共價鍵結於抗菌劑内對應官 在匕南心f基團的表面上。或者是,抗菌劑可以塗佈 面上%H ’然後將基材轉移到欲獲得抗菌效果的表 上。抗_可以併人拋光劑、表“_ 201000010 (cau 1 ks )、黏著劑、尾漆(f i n〗shes )、油漆、犧可聚 合組成物(包括酚系樹脂、矽酮聚合物、氯化橡膠、煤 焦油及環氧組合物,環氧樹脂、聚醢胺樹脂、乙烯樹脂、 彈性體、丙烯酸酯聚合物、氟聚合物、聚酯及聚氨基甲 酸乙酯、膠乳),以傳送到欲獲得抗菌效果的表面。且 可以使用連續或間歇塗佈;也可以處理基材整個表面或 部分表面。 β 應用輿材斜 可以利用任何適當的方法塗佈抗菌劑。較佳地,將 抗菌劑當作塗層塗在包括可共價鍵結於抗菌劑内對應官 此基團之官能基團的表面上。或者是,抗菌劑可以塗佈 在一適當基材,然後將基材轉移到欲獲得抗菌效果的表 面^。抗菌劑可以併入拋光劑、表面清潔劑、填縫劑、 黏著劑、尾漆、油漆、蠟可聚合組成物(包括酚系樹脂、 • 矽酮聚合物、氯化橡膠、煤焦油及環氧組合物,環氧樹 脂、聚醯胺樹脂、乙烯樹脂、彈性體、丙烯酸酯聚合物、 氟聚合物、聚酯及聚氨基曱酸乙酯、膠乳),以傳送到 欲獲得抗S效果的表面。可錢料續或間㈣佈。可 以處理整個表面或部分。 較佳具體實施㈣抗g官能基化試劑可以被用於各 種用途,避免或抑制細菌增長。試劑特別對於抑制Gram_ 正型及Gram-負型細菌生長有效;然而。也可以避免或 18 201000010 抑制其他微生物及細微有機生物,例如黴菌,像是 病毒,及原生物的生長。Gram-正型細 菌具有胜肽基(peptido )聚糖(giyCan)以及多糖 (polysaccharides)及/或壁酸(teichoic acid)作為其CnH2n+i CnH2n I Si(OCH3)3 The degree of quaternization reaction can be varied by adjusting the amount of alkyl halide (or other hydrogen-based divalent carbon-based halide) in the reaction mixture. In the above two polymer structures, the degree of quaternization reaction was 50%. The degree of ruthenium oxidation in the second structure is 25%. It may also be advantageous to utilize a lower degree of quaternization reaction, favoring less than 50%, such as 5% - 45% of the quaternary oxime reaction; however, it is generally preferred to maximize the quaternization reaction' eg More than 50% of the four-level reaction, such as up to 60%, 16 201000010 70%, 80%, battle 95 team or 1_. The degree of oxidation of the ceramsite can be controlled by the degree of secondary reaction, but it is advantageous to maximize the oxidization, especially in applications where extreme speed is required. ~ A single-type repeating unit can be used, or a mixed chemical repeating unit can be obtained by using a suitable mixture of reactants and different molecular moieties. ❹ ❹ The advantage of the above-mentioned secondary reaction is that the reaction step is reduced by two steps than the conventional method of using 3-aminopropyl propyl dimethoxy; The resulting functionalized product (formylated PVP quaternary salt) also has the advantage that it is soluble in water and/or an organic solvent such as methanol, so that it is further processed and made into (iv). This processing step may include performing coating techniques known in the art on the surface of the substrate, such as dipping, dipping, spraying, aerosolizing, spraying, brushing, curtain coating, rolling, silk~ , yellow light process, inkjet and similar technical materials (such as broken glass) = UrT base side group (such as trimethoxy) as a base group; alcohol group formation is very durable and not easy to remove ( For example, being washed off the substrate may be applied by any method. Preferably, the layer of bis::- ί is coated on the surface including the co-bonded to the antibacterial agent in the antibiotic agent. Alternatively, the antibacterial agent can be coated on the surface with %H' and then transferred to the surface to obtain an antibacterial effect. Anti-can be used as a polishing agent, table "_ 201000010 (cau 1 ks ), adhesive, Tail paint (fin), paint, and sacrificial composition (including phenolic resin, anthrone polymer, chlorinated rubber, coal tar and epoxy composition, epoxy resin, polyamide resin, vinyl resin, Elastomers, acrylate polymers, fluoropolymers, polyesters and polyurethanes, latex), It is delivered to the surface for which an antibacterial effect is to be obtained, and continuous or intermittent coating may be used; the entire surface or part of the surface of the substrate may also be treated. β Application of the coffin may be applied by any appropriate method. Preferably, the antibacterial agent is applied. Applying the antibacterial agent as a coating to a surface comprising a functional group covalently bonded to the corresponding group in the antibacterial agent. Alternatively, the antibacterial agent may be coated on a suitable substrate and then the substrate Transfer to the surface to obtain antibacterial effect. Antibacterial agent can be incorporated into polishing agent, surface cleaner, caulking agent, adhesive, tail paint, paint, wax polymerizable composition (including phenolic resin, • anthrone polymer) , chlorinated rubber, coal tar and epoxy composition, epoxy resin, polyamide resin, vinyl resin, elastomer, acrylate polymer, fluoropolymer, polyester and polyethyl phthalate, latex), It can be transferred to the surface to obtain anti-S effect. It can be used for continuous or inter-four (four) cloth. The entire surface or part can be treated. Preferred embodiment (4) Anti-g functionalization reagent can be used for various purposes, avoiding or inhibiting Bacterial growth. Reagents are particularly effective in inhibiting Gram_ positive and Gram-negative bacterial growth; however, it is also possible to avoid or 18 201000010 to inhibit the growth of other microorganisms and fine organic organisms such as molds, viruses, and protozoa. Positive bacteria have peptido glycans (giyCan) and polysaccharides and/or teichoic acid as their
❹ 細胞壁結構的一部份’且其特徵為在Gram-染色程序裡有 藍紫色反應(blue-violet color reaction)。代表性的 Gram-正型細菌包括,但不限於,Jci/zzo/zz/ces1 , Bacillus anthracis, Bifidobacterium spp., Clostridium botulinum, Clostridium perfringens, Clostridium spp., Clostridium tetani,一 A part of the cell wall structure' and characterized by a blue-violet color reaction in the Gram-staining procedure. Representative Gram-positive bacteria include, but are not limited to, Jci/zzo/zz/ces1, Bacillus anthracis, Bifidobacterium spp., Clostridium botulinum, Clostridium perfringens, Clostridium spp., Clostridium tetani,
Corynebacteri um di ph theriae, Corynebacter ium jeikeium, Enterococcus faecal is, Enterococcus faecium, Erysipelo thrix rhusi opa thi ae,Corynebacteri um di ph theriae, Corynebacter ium jeikeium, Enterococcus faecal is, Enterococcus faecium, Erysipelo thrix rhusi opa thi ae,
Eubacterium spp. , Gardnerella vaginalis,Eubacterium spp. , Gardnerella vaginalis,
Gemella morbi 1 lonm, Leuconostoc spp., Mycobacterium abcessus, Mycobacterium avium complex, Mycobacterium chelonae, Mycobacterium fortuitwn, Mycobacterium haemophi 1 ium, Mycobacterium kansasii, Mycobacterium leprae, Mycobacterium marinum, Mycobacterium scrofulaceum, Mycoba cterium smegma tis, Mycobacterium terrae, Mvcobacterium tuberculosis, Mycobacterium ulcerans, Mocardia 19 201000010 spp., Pep tococcus n iger, Pep tos trep toco ecus spp., Proprionibacterium spp. , Staphylococcus aureus, Staphylococcus auricularis, Staphylococcus capitis, Staphylococcus cohnii, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus lugdanensis, Staphylococcus ❹ saccharolyticus, Staphylococcus saprophyticus, Staphylococcus schlei feri, Staphylococcus si mi Ians, Staphylococcus ivarneri,Gemella morbi 1 lonm, Leuconostoc spp., Mycobacterium abcessus, Mycobacterium avium complex, Mycobacterium chelonae, Mycobacterium fortuitwn, Mycobacterium haemophi 1 ium, Mycobacterium kansasii, Mycobacterium leprae, Mycobacterium marinum, Mycobacterium scrofulaceum, Mycoba cterium smegma tis, Mycobacterium terrae, Mvcobacterium tuberculosis, Mycobacterium ulcerans, Mocardia 19 201000010 spp., Pep tococcus n iger, Pep tos trep toco ecus spp., Proprionibacterium spp., Staphylococcus aureus, Staphylococcus auricularis, Staphylococcus capitis, Staphylococcus cohnii, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus lugdanensis, Staphylococcus ❹ saccharolyticus, Staphylococcus saprophyticus, Staphylococcus schlei feri, Staphylococcus si mi Ians, Staphylococcus ivarneri,
Staphylococcus xylosus, (族群 B streptococcus), Streptococcus bo vis, Streptococcus equi, Streptococcus mi ti or, Streptococcus pneumoniaeStaphylococcus xylosus, (B streptococcus), Streptococcus bo vis, Streptococcus equi, Streptococcus mi ti or, Streptococcus pneumoniae
Streptococcus agalactiae Streptococcus anginosus, Streptococcus can is, Streptococcus mi lleri, Streptococcus mu tans, Streptococcus pyogenesStreptococcus agalactiae Streptococcus anginosus, Streptococcus can is, Streptococcus mi lleri, Streptococcus mu tans, Streptococcus pyogenes
Γ 族群 A streptococcus), Streptococcus salivarius,及 《SYrep。Gram— 負型細 菌的特徵在於每個細菌細胞被一雙膜包圍。代表性Gram-負型細菌包括以下,但不限於, calcoaceticus, Actinobaci 1 lus act inomyce temcomi tans, Aeromonas hydrophi la,Str ethnic group A streptococcus), Streptococcus salivarius, and SYrep. Gram - Negative bacteria are characterized by each bacterial cell surrounded by a double membrane. Representative Gram-negative bacteria include, but are not limited to, calcoaceticus, Actinobaci 1 lus act inomyce temcomi tans, Aeromonas hydrophi la,
Alcal igenes xylosoxidans, Bacteroides, 20 201000010 Ο ❹Alcal igenes xylosoxidans, Bacteroides, 20 201000010 Ο ❹
Bacteroides fragi 1 is, Bartonella bacilliformis, Bordetella spp. , Borrelia burgdorferi, Branhawella catarrhalis, Brucella spp., Campylobacter spp. , Chalmydia pneumoniae, Chlamydia psi ttaci, Chlamydia trachomatis, Chromobacterium violaceum, Citrobacter spp., Eikenella corrodens, Enterobacter aerogenes, Escherichia coli, Flavobacterium meningosepticum, Fusobacterium spp., Haemophilus influenzae, Haemophilus spp., Helicobacter pylori, Klebsiella spp., Legionella spp. , Leptospira spp., Moraxella catarrhal is, Morganel la morganii, pneumoniae, Neisseria gonorrhoeae, eningi tides, Pasteurel la Pies I omonas shigel loides, Prevotel la spp. Proteus spp., Providencia rettgeri Pseudomonas aeruginosa, Pseudomonas spp. Rickettsia prowazekii, Rickettsia rickettsii Rochalimaea spp. , Salmonella spp. , Salmonella typhi, Serratia marcescens, Shigella spp., Treponema car a teum, Treponema pallidum, pallidum endemicum,Bacteroides fragi 1 is, Bartonella bacilliformis, Bordetella spp., Borrelia burgdorferi, Branhawella catarrhalis, Brucella spp., Campylobacter spp., Chalmydia pneumoniae, Chlamydia psi ttaci, Chlamydia trachomatis, Chromobacterium violaceum, Citrobacter spp., Eikenella corrodens, Enterobacter aerogenes, Escherichia Coli, Flavobacterium meningosepticum, Fusobacterium spp., Haemophilus influenzae, Haemophilus spp., Helicobacter pylori, Klebsiella spp., Legionella spp., Leptospira spp., Moraxella catarrhal is, Morganel la morganii, pneumoniae, Neisseria gonorrhoeae, eningi tides, Pasteurel la Pies I omonas shigel loides, Prevotel la spp. Proteus spp., Providencia rettgeri Pseudomonas aeruginosa, Pseudomonas spp. Rickettsia prowazekii, Rickettsia rickettsii Rochalimaea spp. , Salmonella spp. , Salmonella typhi, Serratia marcescens, Shigella spp., Treponema car a teum, Treponema Pallidum, pallidum endemicum,
Mycoplasma Neisseria mu 1 toeidaMycoplasma Neisseria mu 1 toeida
TreponemaTreponema
Treponema 21 201000010 pertenue, Veillonella spp. , Vibrio cho 1 erae, Vibrio vulnificus, Yersinia enterocolitica,及 Yersinia pestis 。 較佳具體實施例的試劑可以應用在很多種的表面 上’使其具有抗菌且消除異味的效果。試劑可以用來處 理用在衣料、床及衛浴用亞麻布製品、室内裝潢品及其 他家飾品(墊毯、窗簾、壁紙、地毯料)之織物(織布或 不織布)或纖維,例如膠原質物品(皮革、仿麂皮織物)、 ❹ 纖維素(棉,亞麻)及角質(羊毛,絲)材料;合成纖物及 纖維(聚酯,耐龍,矽膠橡膠,乳膠,塑膠,聚酐,聚 原(ortho)酯,聚醯胺,聚丙烯腈,聚氨基曱酸乙酯, 聚乙烯’聚四氟乙埽,聚填腈(polyphazenes)及對苯二 酉文t乙一 ,天然-合成纖維混成物(例如聚g旨/棉 65:35 ’ DACRON®/棉,耐龍/棉,及其他棉混成物);用於 醫療用途之纖維或纖維(紙毛巾,面紙,衛生用品,衛 生紙’文具用品);玻璃表面,聚合物表面(例如廚房用 ❹ 具内外’底板及壁紙,桌櫃面,家具,儲櫃,個人護理 用品,置納箱’器皿,醫療裝置,乙烯產品,乳膠產品, 拋棄式手套,電子用品,電腦,鍵盤,行動電話,攜帶 式傳呼器,個人數位助理,電話’計算機,手持電子用 品等):油漆及顏料;陶瓷或複合材料表面(例如水槽、 浴缸、淋浴器、馬桶、醫療器材或注入器(implants)); 木材(地板’家具,門窗鑲邊飾,細工家具,其他建築材 22 201000010 料);合成或天然岩石(混擬土,地板,桌櫃面,鋪碑, 建築材料,例如石造建築材料或水泥漿);金屬(廚房器 孤,醫療器材,烹佐表面,門把,桌櫃面,公共衛生的 工業機械裝置,食物,化妝品或醫療器材,儲水槽,管 路);及其他類似物品。 上述抗菌試劑特別適合用於醫療工業儀器或裝置, 不論是拋棄式或可重複使用,例如解剖刀、針、剪刀及 其他用於侵入式手術、治療或診斷過程的用品;可植入 ❹ 醫療設備,包括人工血管,導管,及其他為了移除或傳 輸流體到病人的設備,人工心臟,人工腎臟,整形外科 針,薄板及植入物;導管及其他類型的管(包括泌尿及 膽汁輸送管,氣管内管,可插入式中央靜脈管,導尿管, 洗腎導管,長期導通之中央靜脈導管,周邊靜脈導管, 短期中央靜脈導管,動脈導管,肺管,Swan-Ganz導管, 尿管,腹膜導管)泌尿用器材(包括長期泌尿儀器,包紗 泌尿儀器,人工尿道括約肌,尿道擴張器),分流器(包 ⑩ 括心室或動脈靜脈分流器);義體(包括義乳,人工陰莖, 人工接枝血管,心臟瓣膜,人工關節,人工喉頭,耳科 植入物),血導管部分,迂迴引流管,腦水腫分流器,起 搏器及可植入電擊器,醫療設備,由人員穿戴或攜帶或 由醫護系統設定之醫療齒輪,呼吸治療使用的管子及罐 子(包括供予氧氣、已經溶解喷霧器内之藥物、麻醉劑), 手套,工作裙及面罩,醫療或牙科設備用的手把或纜線, 23 201000010 心臟瓣膜,髖關節植入物,假牙,齒冠,固定器,植牙, 鑽頭及牙科設備等。 試劑也可以用於食物加工工業(例如牛奶,起司及 肉類加工設備的裝罐設備),包裝設備,塑膠窗簾,傳送 帶材料,取出内臟設備,及不鏽鋼表面。水處理用途包 括水冷卻塔,水加熱器,水分送管,公共水儲存塔,私 人水井,及滴水灌溉系統。試劑也可以適合用於空氣過 濾及處理,例如空調系統,空氣清淨機,通風管,加熱 ❹ 單元等。 一般程序 依照下列程序製備曱矽烷化PVP四級鹽。所用的材 料包括聚(4-乙烯吡啶)(42%以甲醇為溶劑之溶液, REILLINE™ 410,MW 20, 000,由美國印度安那波里的 Rei 1 ly Indus tries公司製造);3-氯丙烧三曱氧基石夕烧 (CAS 2530-87-2, KBM-703 ,由日本東京Shin-Etsu化學 ❹ 公司製造);1-氯丁烷(CAS 109-69-3,由比利時AcrosTreponema 21 201000010 pertenue, Veillonella spp., Vibrio cho 1 erae, Vibrio vulnificus, Yersinia enterocolitica, and Yersinia pestis. The reagents of the preferred embodiments can be applied to a wide variety of surfaces to provide an antibacterial and odor eliminating effect. Reagents can be used to treat fabrics (woven or non-woven) or fibers, such as collagen, used in clothing, bed and bathroom linen, upholstery and other home accessories (pads, curtains, wallpaper, carpeting). (leather, suede fabric), 纤维素 cellulose (cotton, linen) and horny (wool, silk) materials; synthetic fiber and fiber (polyester, nylon, silicone rubber, latex, plastic, polyanhydride, poly-origin (ortho) ester, polydecylamine, polyacrylonitrile, polyaminodecanoate, polyethylene 'polytetrafluoroacetic acid, polyphazenes and p-benzoquinone t-ethyl, natural-synthetic fiber mixture (eg polyg/cotton 65:35 'DACRON®/cotton, nylon/cotton, and other cotton blends); fiber or fiber for medical use (paper towels, facial tissue, hygiene products, toilet paper' stationery ); glass surface, polymer surface (eg kitchen interior and exterior 'floor and wallpaper, table top, furniture, storage cabinet, personal care products, collection box' utensils, medical devices, vinyl products, latex products, disposable gloves Electronic supplies, computers, keyboards, mobile phones, portable pagers, personal digital assistants, telephone 'computers, handheld electronics, etc.): paints and pigments; ceramic or composite surfaces (eg sinks, bathtubs, showers, toilets, medical Equipment or implants; wood (floor furniture, door and window trim, fine furniture, other building materials 22 201000010 materials); synthetic or natural rock (mixed soil, floor, table top, monument, building) Materials such as stone building materials or grouts; metal (kitchen solitary, medical equipment, cooking surfaces, door handles, table tops, public health industrial machinery, food, cosmetics or medical equipment, water storage tanks, piping And other similar items. The above antibacterial agents are particularly suitable for use in medical industry instruments or devices, whether disposable or reusable, such as scalpels, needles, scissors and other supplies for invasive surgery, treatment or diagnostic procedures. Implantable ❹ medical devices, including artificial blood vessels, catheters, and others to remove or transport fluids to Human equipment, artificial heart, artificial kidney, plastic surgery needle, sheet and implant; catheter and other types of tubes (including urinary and bile ducts, endotracheal tubes, insertable central venous tubes, catheters, washes) Renal catheter, long-term central venous catheter, peripheral venous catheter, short-term central venous catheter, arterial catheter, pulmonary tube, Swan-Ganz catheter, urinary catheter, peritoneal catheter) urinary equipment (including long-term urinary instruments, urinary instruments, Artificial urethral sphincter, urethral dilator), shunt (including ventricular or arterial venous shunt); prosthesis (including breast, artificial penis, artificial grafted blood vessel, heart valve, artificial joint, artificial throat, ear implant Infusion), blood catheter section, bypass catheter, cerebral edema shunt, pacemaker and implantable electric shock, medical equipment, medical gear worn or carried by personnel or set by the medical system, tubes used for respiratory therapy and Jars (including oxygen, dissolved drugs in the sprayer, anesthetic), gloves, work skirts and masks, medical or Equipment for the hand or with a cable, 23201000010 heart valves, hip implants, dentures, crowns, fixture, dental implants, and dental drill equipment. Reagents can also be used in the food processing industry (eg canning equipment for milk, cheese and meat processing equipment), packaging equipment, plastic curtains, conveyor belt materials, visceral equipment, and stainless steel surfaces. Water treatment uses include water cooling towers, water heaters, water delivery pipes, public water storage towers, private wells, and drip irrigation systems. The reagents can also be used for air filtration and treatment, such as air conditioning systems, air purifiers, air ducts, heating units, etc. General Procedure The decylated PVP quaternary salt was prepared according to the following procedure. The materials used included poly(4-vinylpyridine) (42% methanol-based solution, REILLINETM 410, MW 20,000, manufactured by Rei 1 ly Indus, Inc., Annapur, India); 3-chloropropane Burned trioxane zebra (CAS 2530-87-2, KBM-703, manufactured by Shin-Etsu Chemical Co., Ltd., Tokyo, Japan); 1-chlorobutane (CAS 109-69-3, by Acros, Belgium)
Organics公司製造);氯化丙烯(CAS 107-05-1,由德國 柏林Ferak化學公司製造);1-溴辛烷(CAS 118-83-1, 由 Acros Organics公司製造);1-溴庚院(CAS 629-04-9,由 Acros Organics 製造);氣化苯(CAS 100-44-7);氯化乙基苯(CAS 26968-58-1),包括由比例 為70:30的對位及及鄰位異購物;及甲醇(無水). 24 201000010 聚(4 比咬)經甲醇稀釋,降低黏度,使其容易 處理。再經=量的分子_脫水,以去除殘餘微量水分。 將pvp的固體整至·。應注意,皿linetmi〇聚 (4乙烯口比疋《製造商取得後直接使用,為丽一7〇33_ 氯丙烧三甲ί基錢存在下⑽體。因此,需要維持系 統在無水狀悲,不然就是使水盡量地少。 將經脫水之聚(4-乙稀π比咬)(4〇毫莫爾的乙稀 t定單體重複單元),3〇-36冑莫爾㈣(C4_ c〇及Η 毫莫爾和OM-m 3-氯㈣1氧基魏的混合物倒入 5〇一mlWheatQn玻璃清液瓶,以橡膠塞及銘蓋密封,然後 在95-lG(TG熱油財加熱8-12小時。反應混合物在反應 過程中從二相變成均相溶液,#遠紅外線(ir)波峰從 1600 cm-ι (吡啶環C=N伸長鍵)移到164〇⑽―1(在四級 化反應之後)%即為反應完成。所得產物立即溶於水,形 成一琥珀色清澈溶液。 ❹ 實施例 將脫水的REILLINE™ 410聚(4-乙烯吡啶)(21.0 克,40毫莫爾),1-氣丁烷(32克,33〇毫莫爾), KBM-703 3-氣丙烷三曱氧基矽烷(1.2克,6.0毫莫爾) 及9.0克曱醇的混合物倒入一5〇毫升清液玻螭瓶,密封 並使其在95 C反應12小時。反應混合物開始時是一個 二相液體,但是之後在快要完成反應時就變成均相混合 25 201000010 物。四級聚合物的特徵在於使用KBr丸粒的IR分光 儀,顯示波寺從1598 cm_1 (π比°定環ON)移到1641cm—1 (在四級化反應之後)。產物立即溶於水,形成一淡橘色 清澈溶液。 實施例2到10Made by Organics); propylene chloride (CAS 107-05-1, manufactured by Ferak Chemical Company, Berlin, Germany); 1-bromooctane (CAS 118-83-1, manufactured by Acros Organics); 1-bromo (CAS 629-04-9, manufactured by Acros Organics); gasified benzene (CAS 100-44-7); ethylbenzene chloride (CAS 26968-58-1), including a ratio of 70:30 And adjacent foods; and methanol (anhydrous). 24 201000010 Poly (4 bite) diluted with methanol to reduce viscosity, making it easy to handle. The amount of molecules is dehydrated to remove residual traces of water. The solid of pvp is rounded up to . It should be noted that the dish linetmi 〇 ( (4 口 疋 疋 疋 疋 疋 疋 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造 制造It is to make the water as little as possible. The dehydrated poly (4-ethylene π ratio bite) (4 〇 millimol of ethylene t monomer repeating unit), 3 〇 -36 胄 Mohr (four) (C4_ c〇 And Η Mix a mixture of mMmol and OM-m 3-chloro(tetra)-oxypropan. Pour into a 5ml-WheatQn glass clear bottle, seal with rubber stopper and cover, then heat at 95-lG (TG hot oil) 12 hours. The reaction mixture changed from two phases to a homogeneous solution during the reaction, and the far infrared (ir) peak was shifted from 1600 cm-ι (pyridine ring C=N elongation bond) to 164 〇(10)-1 (in four stages). After the reaction, % is the completion of the reaction. The obtained product was immediately dissolved in water to form an amber clear solution. 实施 Example Dehydrated REILLINETM 410 poly(4-vinylpyridine) (21.0 g, 40 mmol), 1 - gas butane (32 g, 33 〇 mM), KBM-703 3-propane propane trimethoxy decane (1.2 g, 6.0 mmol) and 9.0 g of sterol The mixture was poured into a 5 ml ml clear glass bottle, sealed and allowed to react at 95 C for 12 hours. The reaction mixture was initially a two phase liquid, but then became homogeneously mixed 25 201000010 upon completion of the reaction. The quaternary polymer is characterized by an IR spectrometer using KBr pellets, showing that the wave temple is moved from 1598 cm_1 (π to ° ring ON) to 1641 cm-1 (after the quaternization reaction). The product is immediately soluble in water. A light orange clear solution is formed. Examples 2 to 10
實施例2到10中每個的實驗程序都與實施例1相 同,不同的是實施例1所用的1-氯丁烷(1-C1C4)在實施 例2裡分別被1-溴庚烷(1-BrC?)取代;實施例3裡被1-溴辛烷(l-BrC〇取代;實施例4裡被氯化苯(Bz C1) 取代;實施例5裡被氣化乙基苯(E Bz Cl)取代;實施例 6裡被氯化丙烯(Ally C1)取代;實施例7裡被氣化曱基 苯(MBzCl)取代;;實施例8裡被1-氯丁烷及氣化苯取 代;實施例9裡被1-氣丁烷及氯化乙基笨取代;及實施例 10裡1-氣丁烷和氯化甲基苯取代。每個實施例中反應混 合物的組成如表1 a所示。The experimental procedures for each of Examples 2 to 10 were the same as in Example 1, except that 1-chlorobutane (1-C1C4) used in Example 1 was respectively subjected to 1-bromoheptane in Example 2 (1). -BrC?) substituted; Example 3 was replaced by 1-bromooctane (1-BrC〇; Example 4 was replaced by chlorinated benzene (Bz C1); Example 5 was gasified ethylbenzene (E Bz Cl) is substituted; in Example 6, it is substituted by propylene chloride (Ally C1); in Example 7, it is substituted by vaporized nonylbenzene (MBzCl); and in Example 8, it is substituted by 1-chlorobutane and gasified benzene; In Example 9, it was substituted with 1-hexane butane and ethyl chloride; and in Example 10, 1-butane and methylbenzene were substituted. The composition of the reaction mixture in each example is shown in Table 1 a. Show.
表 la. 貫施 反應物(毫莫爾) 例 Ally 1-Cl Bz E Bz 1-BrC 1-Br M Bz KBM-70 PVP Cl c4 Cl Cl 8 Ct Cl 3 1 40 — 33 6 2 40 36 — 2 26 201000010Table la. Transacted reactants (mmolol) Example Ally 1-Cl Bz E Bz 1-BrC 1-Br M Bz KBM-70 PVP Cl c4 Cl Cl 8 Ct Cl 3 1 40 — 33 6 2 40 36 — 2 26 201000010
比較實施例Comparative example
下列比較實施例的程序實質上與上述實施例相同, 但是不同的是沒有使用KBM-703 3~氯丙烷三曱氧基矽 烷,且REILLINE™410聚(4-乙烯吡咬)係不經過脫水直接 使用。比較實施例裡反應混合物的組成如表此所述。 表lb· 實施例 反應物 (毫莫爾) Ally 1-C1 Bz E Bz HBr 1-Br M Bz PVP Cl C4 Cl Cl Cs Ct Cl 實施例1之非曱矽烷 40 — 37.4 — — — 27 201000010 類似物 實施例2之非曱矽烷 類似物 40 30 — 實施例3之非曱矽烷 類似物 40 30 — — 實施例4之非曱矽烷 類似物 40 — — 36 — — — --- 實施例5之非曱矽烷 類似物 40 — — — 24 — — --— 實施例6之非曱矽烷 類似物 40 30 實施例7之非曱矽烷 類似物 40 37 實施例8之非曱矽烷 類似物 40 — 17.5 17. 5 — — — — 實施例9之非曱矽烷 類似物 40 — 17.5 — 17.5 — — — 實施例10之非曱矽烷 類似物 40 — 17.5 17.5 28 201000010 抗菌測試 測疋經固定之_抗菌劑的抗菌活性的程序在japan industrial Standard (JIS) Z2801 (抗菌物件,抗菌測 菌ί果’建立於西元2000年12月20曰)及歷 活性的標準測試方法)的^^定經固定抗菌劑之抗菌 、J 4條件後被加以模組化。 測試溶液^ 依序將〇·5克醋酸及2 J的...... 烈攪拌,以確保完成A」杬囷溶液。將所得抗菌溶液劇 液。溶液在室^下保此基的水解,結果形成一清澈溶 以用來製備實施例2到寺清澈超過二個星期。類似方法可 1 0中四級產物的溶液。 水溶液以溶液形式相加.b克貫施例1所得之四級產物 液。將含20重量%、、舌 不用隔離及純化,即得一水溶 水,得到—濃度〇 5 ^生成分的溶液加入100毫升蒸餾 烈攪拌,以放π^ °的抗菌溶液。將所得抗菌溶液劇 ❹ 使用顯微鏡試片 Slides,德國 Menz 嘴(SuperFrost® Microscope 面。顯微鏡坡璃試司製造)作為測試矽質基材表 得之溶液中。在室、、订峰性沖洗,然後浸潰於上述所 出,放入100。(:烤箱;^置30分鐘後,將玻璃從溶液中取 目乾燥3〇分鐘。並重複此步驟三遍。 29 201000010 依照下列 JIS L 0217 (Care Labeling 〇f TextileThe procedures of the following comparative examples are substantially the same as those of the above examples, except that KBM-703 3~chloropropane tridecyloxydecane is not used, and REILLINETM 410 poly(4-vinylpyridinium) is not directly dehydrated. use. The composition of the reaction mixture in the comparative examples is as described herein. Table lb. Example reactants (mimo) Ally 1-C1 Bz E Bz HBr 1-Br M Bz PVP Cl C4 Cl Cl Cs Ct Cl Example 1 non-decane 40 — 37.4 — — — 27 201000010 Analogs The non-decane analog of Example 2 40 30 - the non-decane analog of Example 3 40 30 - the non-decane analog of Example 4 - 36 - - - - -矽Calc Analog 40 — — 24 — — — — The non-decane analog of Example 6 40 30 The non-decane analog of Example 7 40 37 The non-decane analog of Example 8 — 17.5 17. 5 — — — — The non-decane analog of Example 9 40 — 17.5 — 17.5 — — — The non-decane analog of Example 10 — 17.5 17.5 28 201000010 Antibacterial test for the antibacterial activity of the immobilized antibacterial agent The procedure is based on the japan industrial standard (JIS) Z2801 (antibacterial object, antibacterial measurement ί fruit 'established in December 20, 2000) and the standard test method of activity Antibacterial antibacterial agent, the condition after the J 4 be modular. Test solution ^ In order to ensure the completion of the A" solution, 〇·5g of acetic acid and 2 J of ... are stirred vigorously. The resulting antibacterial solution was drowned. The solution was hydrolyzed under the chamber to form a clear solution which was used to prepare Example 2 to the temple for more than two weeks. A similar method can be used to provide a solution of the fourth grade product. The aqueous solution was added in the form of a solution. The quaternary product liquid obtained in Example 1 was used. 20% by weight, the tongue is not isolated and purified, that is, one water is dissolved in water, and the solution having the concentration of ^ 5 ^ is added to 100 ml of distillation and vigorously stirred to put an antibacterial solution of π^ °. The resulting antibacterial solution was visualized using a microscope test slide, the German Menz mouth (SuperFrost® Microscope surface, manufactured by Microscope Glass Tester), as a solution for testing the tantalum substrate. In the chamber, the peak is rinsed, then immersed in the above, and placed in 100. (:Oven; After setting for 30 minutes, the glass was dried from the solution for 3 minutes. This step was repeated three times. 29 201000010 According to the following JIS L 0217 (Care Labeling 〇f Textile
Goods)標準程序製備織物。所用之織物為1〇〇%平織(未 染色)針織天然白色棉布’在微生物培植前以〇· 1 % Tween-20溶液及壓熱器消毒。 测試規格 在JIS L 1902 (織品產物上抗菌活性及功效的測試) 之後,將測試結果與對照組比較後,以細菌菌叢減少數 量百分比做為經實施例1-1〇所得四級產物處理之表面的 β 抗菌活性的量化。在步驟中,1 〇微升整細菌濃度調整到 1-5 X 105個細胞數/毫升(根據JIS l 1902之步驟 8. 1· 2)之測試接種物利用已經消毒的微量滴管培種在已 經/肖毋的《式片玻璃上。測試片被已經消毒的薄玻璃片輕 輕地覆蓋,並且在37°C培種18小時。根據jis L 1902的 步驟10. 1. 3,在每個測試片以2〇毫升冰生理食鹽水沖掉 細菌後計數細菌菌叢的數量。當成長值F大於丨.5時,判 斷此測試有效,如果成長值小於1. 5,則結果放棄並且重 〇 新進行/則5式。測试的細菌菌型包括 aureus (ATCC29737)及 Escherichia coli (ATCC10536)。 在沖洗循環1,2及3後經處理顯微鏡試片玻璃之抗 菌活性(抗測試結果係列於表 2。如數據所示,所述四級產物均展現良好的抗菌活性及 耐用性,氯化苯衍生物展現特別高的抗菌活性及耐用性。 30 201000010 表2. 實驗 夕菌叢(%)在玻璃表面上的 減少情況 清洗循環1 清洗循環2 清洗循環3 實施例1 (1-C1C4) 97.25 96.91 71.78 實施例1之非曱矽烷 94.3 54.5 — 實施例2 (1-BrO) 80.9 73.74 78. 1 實施例2之非甲矽烷 類似物 98.7 14.3 ___ 實施例3 (l-BrCs) 82.9 63.8 70.16 實施例3之非曱矽烷 類似物 92.5 6.0 ___ 實施例4 (Bz C1) 99.45 97.42 91.29 實施例4之非曱矽烷 類似物 90.75 58 ___ 實施例5 (E Bz C1) 98.75 92 — 實施例5之非曱矽烷 類似物 95.5 74.5 ___ 實施例6 (Ally C1) 99.3 97.96 — 31 201000010 實施例6之非曱矽烷 類似物 99.85 75.77 ___ 實施例8 (1-C1C4 + Bz Cl) 99.7 80.44 ___ 實施例8之非甲矽烷 類似物 99.85 30.07 ___ 實施例 9 (1-C1C4 + E Bz Cl) 99.99 94. 6 ___ 實施例9之非曱矽烷 類似物 89.19 28.76Goods) Standard procedure for preparing fabrics. The fabric used was 1% woven (undyed) knitted natural white cotton cloth sterilized with 〇·1% Tween-20 solution and autoclave before microbial cultivation. After the test specification was tested in JIS L 1902 (antibacterial activity and efficacy on fabric products), the test results were compared with the control group, and the percentage of bacterial flora reduction was used as the fourth-grade product obtained in Example 1-1. Quantification of the surface antibacterial activity of beta. In the step, the concentration of 1 〇 microliter of the bacteria is adjusted to 1-5 X 105 cells/ml (according to JIS l 1902, step 8.1.2), the inoculum is sterilized using a micropipette that has been sterilized. Already / Xiao Wei's "glass on the glass. The test piece was lightly covered with the already sterilized thin glass piece and cultured at 37 ° C for 18 hours. According to step 10.1.3 of jis L 1902, the number of bacterial flora was counted after each test piece was washed with 2 ml of ice physiological saline. When the growth value F is greater than 丨.5, the test is judged to be valid. If the growth value is less than 1.5, the result is discarded and the new process is repeated. The bacterial strains tested included aureus (ATCC 29737) and Escherichia coli (ATCC 10536). The antibacterial activity of the treated microscopy glass after the flushing cycles 1, 2 and 3 (the anti-test results are shown in Table 2. As shown by the data, the quaternary products exhibit good antibacterial activity and durability, chlorinated benzene The derivative exhibits particularly high antibacterial activity and durability. 30 201000010 Table 2. Reduction of the experimental bacterium cluster (%) on the glass surface Cleaning cycle 1 Cleaning cycle 2 Cleaning cycle 3 Example 1 (1-C1C4) 97.25 96.91 71.78 Non-decane of Example 1 94.3 54.5 - Example 2 (1-BrO) 80.9 73.74 78. 1 Non-methane derivative of Example 2 98.7 14.3 ___ Example 3 (l-BrCs) 82.9 63.8 70.16 Example 3 Non-decane analog 92.5 6.0 ___ Example 4 (Bz C1) 99.45 97.42 91.29 Non-decane analog of Example 4 90.75 58 ___ Example 5 (E Bz C1) 98.75 92 - Example 5 is similar to non-decane 95.5 74.5 ___ Example 6 (Ally C1) 99.3 97.96 — 31 201000010 Non-decane analog of Example 6 99.85 75.77 ___ Example 8 (1-C1C4 + Bz Cl) 99.7 80.44 ___ Example 8 is similar to non-methane 99.85 30.07 ___ Example 9 (1-C1C4 + E Bz Cl) 99.99 94. 6 ___ Non-decane analog of Example 9 89.19 28.76
在沖洗循環1, 2及3後經處理棉織物之抗 仙厂己仍的抗菌活性測試結果係列於表 3,如數據所示,每個四級產物都展現良好的抗菌活性及 Q 耐用性。抗菌塗層的耐用性,即使在重複沖洗循環,都 是相當地兩。 ^__3. 實驗 5! 菌叢(%)在棉織物上的 減少情況 32 201000010 清洗循環0 清洗循環 10 清洗循環 20 實施例1 (1-C1C4) 96.53 99.8 91.33 實施例1之非曱矽烷類 似物 99.92 99. 58 98.2 實施例4 (Bz C1) 97.64 99. 5 98.09 實施例4之非曱矽烷類 似物 93.85 99.3 97.32 實施例5之非甲矽烷類 似物 99.996 ___ 99. 996 實施例6之非曱矽烷類 似物 99. 978 一一一 99.997 實施例7之非曱矽烷類 似物 99.971 ___ 99.997 實施例8之非甲矽烷類 似物 99. 949 ___ 99. 964 實施例10之非曱矽烷類 似物 99. 947 ___ 99. 856 在重複沖洗循環後也測試經處理棉織物抗^ c σ / i 33 201000010 的抗菌活性。如表4之數據所示,經 經過重複稱洗循環後在棉_物μ _之四級產物在 用=。 ^織物上展現極佳抗菌活性及耐 表4. 實驗 -—--- E. Col 清洗循 環0 ~~--- 清洗循 環10 3)在棉織 清洗循 環20 ------ 物上的滅 清洗循 環30 ~--—-- S少情況 清洗循 環50 實施例1 U-C1C4) 之非甲矽烷類似物 98.94 99.39 99. 11 98. 09 96. 93 表5的數據顯示’在單次沖洗循環後,經所選四級 產物處理之玻璃表面對E coli展現良好的抗菌活性。 表5 實驗 足函叢(%)在玻璃表面上的減 少情況 清洗循環1 實施例1 (1-C1C4) 97.7 實施例1之非甲矽烷類似 物 50 實施例4 (Bz C1) 98.8 實施例4之非甲矽烷類似 85.4 34 201000010 物 實施例5 (E Bz C1) 99.6 實施例5之非曱矽烷類似 物 99.6 上述表中也提供實施例中選出四級產物之無矽烷配 對物(counterpart)(非曱矽烷類似物)的數據。對於非 ❹ 矽質用途(例如棉纖維、合成化纖或其他天然纖維)而 言’雖然不如曱矽烷產物快速,但仍展現令人滿意的抗 菌活性及耐用性。較佳具體實施例的聚合性細菌組成物 可以透過併入其聚合物主鏈之甲矽烷基來共價鍵結到矽 質材料表面,或穩固地接到天然纖維(例如棉)及合成 纖維(例如T/C,一種商標名為DACRON®的聚(對苯二酸乙 二酯)與棉以35/65比例混成的合成/天然混成物,以及 透過不用曱矽烷基基團而是利用長鏈忍受多次清洗卻不 〇 失去抗菌效果的物理交互作用。相對地,短鏈、單體類 似物氣化苯甲烴按(benzaIkonium chloride)(實施例 8)並非具抗清洗的能力。較佳具體實施例之菌類非曱矽 燒類似物在織品上的長時間抗菌效果是一項最令人驚奇 的特徵。 對於包括天然與合成纖維二種的織品用途而言’非 曱矽烷化PVP四級鹽就如同甲矽烷化PVP四級鹽般耐清 35 201000010 洗,因此可以提供節省成本及容易使用的優點。芳烷基 化合物的PVP四級鹽,例如氯化笨,氣化曱基苯,及氯 化乙基苯,均為有效的抗菌劑。單一形式及混合形式都 是有效的抗菌形式。較高程度的四級化反應,PVp四級 鹽極性越強,因此有利於水溶性;然而,在織品用途裡, PVP四級鹽一旦連接到纖維的多孔表面時其水溶性則不 會對耐清洗性造成任何的負面影響。 表6及表7提供有關所用非甲石夕烧類似物在τ/c上 ❹ 抗尤&h and Z. 服⑽/此的抗菌活性之數據。表8 及表9提供有關所用非甲矽烷類似物在棉織物上抗$ 及/5. 的抗·囷活性之數據。所測試的 每個非曱矽烷類似物在重複清洗循環後都展現出極佳抗 翻活性(請參考表6、表7及表8所示之數據)。表9 則根據測試方法(European Pharmacopoeia test methodology)’提供連續〇、6、24、及48小時時間 間隔,已被處理纖維及未被處理纖維(對照組)微生物 ❹ 群落數的差異。 表6 實驗 £ 菌叢(%)在T/C上的減少情 況 清洗循環0 清洗循環20 實施例4之非甲矽烷類似 99. 979 99.982 36 201000010 ❹ Ο 表7 實驗 K. pneumoniae ATCC 4352滴叢(%)在τ/C上的減少 情況 清洗循環0 清洗循環10 實施例1之非甲矽烷類似 物 99.997 99.988 實施例4之非甲矽烷類似 物 ----- -------1 99. 998 99. 998 物 實施例8之非曱矽烷類似 物 99.999 99. 74 氯化笨甲烴銨 -—_ 99.999 80.9 表8 〜---------- 實驗 S. aureus ATCC 29737菌叢(%)在棉織物上的 減少情況 L. ----------* 清洗循環0 清洗循環20 37 201000010 實施例4之非甲矽烷類似 物 99.98 99.98 實施例8之非曱矽烷類似 物 99.99 -—-- 99. 74 氯化苯甲烴銨 99. 99 80.9 表9 實驗 ATCC 2785 P. aeruginosa 3囷叢(%)在棉織物上的減少情 況 0 Hour 6 Hour 24 Hour 48 Hour 實施例4 96.465 99. 977 99. 997 99.996 較佳具體實施例的官能化試劑對Gram-正型細菌 (例如ai/rei/s)及Gram-負型細菌(例 如 Escherichia Coli, Pseudomonas aeruginosa, 皆有抗菌活性。其特別適合保護 矽質材料,纖維素材料,角質材料及膠原質材料,例如 織品、皮革、木材、玻璃、陶瓷、岩石及其他建築材料。 藉由塗佈一適當中間層或使表面進行中間的官能化反 應,也可以使其他類型的表面(例如金屬表面,聚合物 表面及其相似表面)具有抗菌效果。 38 201000010 不論具有甲矽烷基圑與否,經較佳具體實施例的官 能化試劑處理過的棉纖維展現出極佳的耐用性。經處理 之纖維能夠忍受洗衣機清洗循環,可作為襪子與内衣等 貼身衣物的抗菌塗層。 所在此所用之有參考資料皆以參考方式併入本發 明。對於以參考方式整個併入本發明之公開案、專利案 或專利申請案,舉凡與本發明有相互衝突矛盾者,本發 明欲予以放棄及/取代該矛盾内容。 ❹ 在此所稱“包括”指同義之含有、包含或其特徵 在於,為開放性解釋或閉鎖式解釋,並且不排除額外、 未提及元素或方法步驟。 所有表示成分數量、反應條件及用於說明書及申請 專利範圍内的數字數量應暸解在所有實例裡可以用” 約”來擴大解釋。因此,除非有矛盾,說明書及申請專 利範圍内所陳述之數字是個近似值,可以根據本發明應 該要獲得的特質而改變。至少在不故意限制申請專利範 〇 圍之等效性應用下,每個數字應該實質的位數且為一般 所知者。 上述說明係揭露本發明之一些方法及材料。本發明 允許有針對方法及材料,以及製造方法及設備的等效性 變化。此變化將對熟習此項技藝者而言不難從本發明所 揭露或實施思及。因此,以上所述僅為本發明之較佳可 行實施例,非因此即侷限本發明之專利範圍,故舉凡運 39 201000010 用本發明說明書及圖式内容所為之等效結構變化,均同 理皆包含於本發明之範圍内,合予陳明。 【圖式簡單說明】 無 【主要元件符號說明】The results of the antibacterial activity test results of the treated cotton fabrics after the washing cycles 1, 2 and 3 are shown in Table 3. As shown by the data, each of the four grades exhibited good antibacterial activity and Q durability. The durability of the antimicrobial coating is quite two even during repeated rinse cycles. ^__3. Experiment 5! Reduction of flora (%) on cotton fabrics 32 201000010 Wash cycle 0 Wash cycle 10 Wash cycle 20 Example 1 (1-C1C4) 96.53 99.8 91.33 Example 1 non-decane analog 99.92 99. 58 98.2 Example 4 (Bz C1) 97.64 99. 5 98.09 Non-decane analog of Example 4 93.85 99.3 97.32 Non-methane derivative of Example 5 99.996 ___ 99. 996 Example 6 is similar to non-decane 99. 978 一 一 99.997 Non-decane analog of Example 7 99.971 ___ 99.997 Non-methane derivative of Example 8 99. 949 ___ 99. 964 Example 10 non-decane analog 99. 947 ___ 99 856 The antibacterial activity of the treated cotton fabric against ^ c σ / i 33 201000010 was also tested after repeated rinse cycles. As shown in the data in Table 4, after the repeated weigh cycle, the product of the fourth grade in the cotton material μ is used. ^Excellent antibacterial activity and resistance on the fabric. 4. Experiment----- E. Col cleaning cycle 0 ~~--- cleaning cycle 10 3) on the cotton cleaning cycle 20 ------ Exhaust cleaning cycle 30 ~----- S less case cleaning cycle 50 Example 1 U-C1C4) Non-methane analog 98.94 99.39 99. 11 98. 09 96. 93 The data in Table 5 shows 'in a single rinse After cycling, the glass surface treated with the selected quaternary product exhibited good antibacterial activity against E coli. Table 5 Reduction of Experimental Footnote Cluster (%) on Glass Surface Cleaning Cycle 1 Example 1 (1-C1C4) 97.7 Non-Methane Analogue 50 of Example 1 Example 4 (Bz C1) 98.8 Example 4 Non-methane is similar to 85.4 34 201000010. Example 5 (E Bz C1) 99.6 Non-decane analog of Example 5 99.6 The above table also provides a non-decane counterpart of the quaternary product of the examples (non-曱) Data for decane analogs). For non-ruthenium use (such as cotton fiber, synthetic fiber or other natural fiber), although not as fast as the decane product, it still exhibits satisfactory antibacterial activity and durability. The polymerizable bacterial composition of the preferred embodiment can be covalently bonded to the surface of the enamel material through a mercaptoalkyl group incorporated into its polymer backbone, or can be firmly attached to natural fibers (such as cotton) and synthetic fibers ( For example, T/C, a synthetic/natural blend of poly(ethylene terephthalate) under the trade name DACRON® and 35/65 in cotton, and long chains without the use of a decyl group Tolerate multiple physical cleanings without losing the physical interaction of antibacterial effects. In contrast, short-chain, monomeric analogs of benzalkonium chloride (Example 8) are not resistant to cleaning. The long-term antibacterial effect of the fungal non-smoldering analogs of the examples on fabrics is one of the most surprising features. For non-decylated PVP quaternary salts for both fabrics including natural and synthetic fibers. Just like the methylated PVP quaternary salt, it can provide the advantages of cost saving and easy to use. PVP quaternary salts of aralkyl compounds, such as chlorinated stupid, vaporized nonylbenzene, and chlorine Chemical Base benzene is an effective antibacterial agent. Both single and mixed forms are effective antibacterial forms. Higher degree of quaternization reaction, the stronger the polarity of PVp quaternary salt, is therefore beneficial to water solubility; however, in fabric use In the case where the PVP quaternary salt is attached to the porous surface of the fiber, its water solubility does not have any negative impact on the washability. Tables 6 and 7 provide information on the non-metallurgical analog used on τ/c. ❹ Anti-Of <h and Z. Service (10)/This data on antimicrobial activity. Tables 8 and 9 provide data on the anti-囷 activity of the non-methane analogs used on cotton fabrics against $ and /. Each of the non-decane analogs tested exhibited excellent anti-folding activity after repeated washing cycles (please refer to the data shown in Table 6, Table 7, and Table 8). Table 9 is based on the test method (European Pharmacopoeia test) Methodology' provides the difference in the number of microbial communities in the treated, untreated, and untreated fibers (control group) at intervals of 6, 24, and 48 hours. Table 6 Experiments £ Flora (%) at T/C Reduction on the cleaning cycle 0 clear Cycle 20 The non-methane of Example 4 is similar to 99. 979 99.982 36 201000010 ❹ Ο Table 7 Experimental K. pneumoniae ATCC 4352 Drop plexus (%) reduction on τ/C Wash cycle 0 Wash cycle 10 Example 1 Formane analog 99.997 99.988 Non-methane analog of Example 4-----------1 99. 998 99. 998 Example 9 Non-decane analog 99.999 99. 74 Chlorination Stupid Ammonium Ammonium - _ 99.999 80.9 Table 8 ~---------- Experimental S. aureus ATCC 29737 flora (%) on cotton fabric reduction L. -------- --* Wash cycle 0 Wash cycle 20 37 201000010 Non-methane analog of Example 4 99.98 99.98 Non-decane analog of Example 8 99.99 - 99-74 Benzolammonium chloride 99. 99 80.9 9 Experimental ATCC 2785 P. aeruginosa 3 囷 (%) reduction on cotton fabric 0 Hour 6 Hour 24 Hour 48 Hour Example 4 96.465 99. 977 99. 997 99.996 Preferred embodiment of the functionalization reagent to Gram - positive bacteria (eg ai/rei/s) and Gram-negative bacteria (eg Escherichia Coli, Pseudomonas aeruginosa, both Antibacterial activity. It is especially suitable for the protection of tantalum materials, cellulosic materials, keratinous materials and collagen materials such as fabrics, leather, wood, glass, ceramics, rock and other building materials. Other types of surfaces, such as metal surfaces, polymeric surfaces and similar surfaces, can also be rendered antimicrobial by coating a suitable intermediate layer or by subjecting the surface to an intermediate functionalization reaction. 38 201000010 The cotton fiber treated with the functionalizing agent of the preferred embodiment exhibits excellent durability regardless of whether it has a carbaryl oxime or not. The treated fibers are able to withstand the washing cycle of the washing machine and can be used as an antibacterial coating for close-fitting clothing such as socks and underwear. References used herein are hereby incorporated by reference. To the extent that the disclosure, patent, or patent application of the present invention is incorporated by reference in its entirety, the present disclosure is intended to waive and/or replace the contradictions. ❹ “Inclusion” as used herein refers to the inclusion, inclusion, or characteristic of synonymy, as an open or blocked interpretation, and does not exclude additional, unmentioned elements or method steps. All quantities indicating the ingredients, reaction conditions, and numbers used in the specification and the scope of the patent application should be understood to extend the interpretation in all instances. Therefore, unless stated to be inconsistent, the numbers stated in the specification and claims are approximations and may vary depending on the characteristics to be obtained in accordance with the invention. At least without deliberately limiting the equivalence of the patent application, each number should be a substantial number of bits and is generally known. The above description discloses some of the methods and materials of the present invention. The present invention allows for equivalent changes to methods and materials, as well as manufacturing methods and equipment. This change will be readily apparent to those skilled in the art from this disclosure. Therefore, the above description is only a preferred embodiment of the present invention, and thus is not intended to limit the scope of the invention. Therefore, the equivalent structural changes of the present invention and the contents of the drawings are the same. It is included in the scope of the present invention and is combined with Chen Ming. [Simple description of the diagram] None [Main component symbol description]
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/144,474 US20090081152A1 (en) | 2007-06-26 | 2008-06-23 | Antimicrobial compositions and methods of making same |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201000010A true TW201000010A (en) | 2010-01-01 |
TWI353217B TWI353217B (en) | 2011-12-01 |
Family
ID=41600267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW097142335A TW201000010A (en) | 2008-06-23 | 2008-11-03 | Antimicrobial compositions and methods of making same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2010006809A (en) |
TW (1) | TW201000010A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI465343B (en) * | 2010-07-30 | 2014-12-21 | Univ Nat Formosa | Hybrid self - assembly molecular structure and its preparation method for reducing spore germination rate |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015002791A2 (en) * | 2012-08-13 | 2017-07-04 | Camlog Biotechnologies Ag | secondary part, joint, dental implant, gum shaper, impression part, dental implant system and method for producing an implant |
-
2008
- 2008-11-03 TW TW097142335A patent/TW201000010A/en unknown
-
2009
- 2009-06-02 JP JP2009149143A patent/JP2010006809A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI465343B (en) * | 2010-07-30 | 2014-12-21 | Univ Nat Formosa | Hybrid self - assembly molecular structure and its preparation method for reducing spore germination rate |
Also Published As
Publication number | Publication date |
---|---|
JP2010006809A (en) | 2010-01-14 |
TWI353217B (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5872465B2 (en) | Polymer coatings containing methoxyethyl acrylate units synthesized by surface-initiated atom transfer radical polymerization | |
US8092815B2 (en) | Antimicrobial solid surface materials containing chitosan-metal complexes | |
CN102947237B (en) | The medical articles of biocide coating | |
JP2007502893A (en) | Method for producing antimicrobial article by reacting chitosan with amino-reactive polymer surface | |
CN106519245B (en) | A kind of antibacterial siloxanes and preparation method thereof | |
US20060177490A1 (en) | Chitosan-base antimicrobial thermoplastic polymer blends | |
CN1522148A (en) | Surface amphiphilic polymers as anti-infectives | |
CN1604945A (en) | Antimicrobial polyolefin articles and methods for their preparation | |
JP2009527486A (en) | Production of antibacterial surfaces using dendrimer biocides | |
JP2016508532A (en) | Antimicrobial polymer | |
US7541398B2 (en) | Method for transformation of conventional and commercially important polymers into durable and rechargeable antimicrobial polymeric materials | |
CN111138571B (en) | Polyvinylpyrrolidone-iodoform biomimetic complex polymer and preparation method thereof | |
TW201000010A (en) | Antimicrobial compositions and methods of making same | |
US20140370064A1 (en) | Film-forming compositions of self-crosslinkable nanogel star polymers | |
JP2021101017A (en) | Modified polyester having antibacterial properties and use of modified polyester | |
EP2400998A2 (en) | Medical devices having improved mechanical performance | |
KR101255528B1 (en) | Method for transformation of conventional and commercially important polymers into durable and rechargeable antimicrobial polymeric materials | |
US20120276040A1 (en) | Antimicrobial compositions and methods of making same | |
EP2009031B1 (en) | Antimicrobial compositions and methods of making same | |
CN112739763B (en) | Antibacterial plastic, manufacturing method thereof and antibacterial plastic article manufactured by same | |
WO1994014872A1 (en) | Polycationic polymer and polycationic bactericidal/algicidal agent | |
US20240067843A1 (en) | Biocidal polymer for long-term surface protection | |
Schofield et al. | A substrate-independent approach for bactericidal surfaces | |
JPWO2013015307A1 (en) | Pathogenic factor production inhibitory fiber and method for producing the same | |
HK1126802A (en) | Antimicrobial compositions and methods of making same |